Abstract
AbstractVisual loss in relation with cancer has greatly increased in adult as in child. Not only because improvement of diagnostic techniques, but because survival rate has dramatically improved. Acute visual loss may be associated to direct or metastatic involvement of the eye or may be a consequence of cancer therapy including chemotherapy, radiation as newer modality like intra‐arterial injections. Considering the possible immunodysfunction in these patients infection as autoimmune disorders should be considered in the differential diagnosis of acute uni or bilateral visual loss. Clinical features and therapeutic options will be discussed through clinical cases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
